Rajiv Khatau

Rajiv Khatau is Managing Director of LODAAT Pharma, an innovative, science-based research firm specializing in botanical ingredients, generic pharmaceuticals and natural medicine. With more than 20 years of experience with the US and emerging markets, Mr. Khatau and his science team are acknowledged as a creative force in understanding and researching small molecules, global trends and the Nutraceutical/ Pharmaceutical industry.

LODAAT is renowned for its worldwide efforts in health issues affecting women and children, specifically in the realm of oncology, cardiovascular, prenatal and dietary supplements. The firm has partnerships with leading hospitals and pharmaceutical firms in Latin America, SE Asia, Middle East, and Sub-Saharan Africa; and has registrations of major pharmaceutical products to reduce key diseases in these markets.

As a testament to LODAAT’s innovation, the LODAAT science team was awarded Best Exporter by The State of Illinois (2014, and 2016), one of the highest accolades from the Governor’s Office.

On the academic front, LODAAT has developed revolutionary technological innovations and clinical trials utilizing published research from MIT, UC Berkley, Cambridge University, and collaborations with the University of Michigan.

Mr. Khatau is a well-respected speaker on the international circuit. He has been invited to speak at major global conferences in Geneva, Barcelona, Paris, Sao Paulo, Shanghai, and throughout the United States.

Mr. Khatau has been honored by the Tata India Leadership Summit, the Wharton Forum, and The US Department of Commerce. He holds a Bachelor of Science from The University of Southern California, and an MBA from The University of Chicago. He resides in the Chicago-area.